Replies to post #50738 on PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

I totally disagree. I learned a lot of new info. I guess it depends on what you were looking for.

Just one example, the 2b trial design was changed after input from oncologists who will have patients in the trial.

Those who are really interested in determining what's going on should listen to the call and make their own judgement.